Neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system. The new study provides the most detailed mapping of ...
This executive interview, sponsored by BeiGene, is with Jan-Henrik Terwey, Vice President, Medical Affairs Europe at BeiGene.
Evaxion Biotech has completed subject dosing in the Phase II trial of EVX-01, for the treatment of advanced melanoma.
Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...
When gut bacteria breaks down plant fiber, they produce two compounds that act on genes to help prevent the growth of cancers ...
Researchers have discovered that mouse PD-1 is significantly weaker than human PD-1, calling into question their reliability ...
The Food and Drug Administration has approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma.
Hosted on MSN11d
FDA grants ODD to Tempest’s hepatocellular carcinoma treatmentThe US Food and Drug Administration has granted orphan drug designation (ODD) to Tempest Therapeutics' oral, selective ...
A novel molecular tool developed by a Lehigh University professor of biological sciences is enabling scientists to precisely ...
Skin allergies are often worsened by psychological stress, but the underlying mechanisms remain poorly understood.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback